Development and Characterization of a Novel Non-Lytic Cancer Immunotherapy Using a Recombinant Arenavirus Vector Platform

Overview of attention for article published in Frontiers in oncology, October 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 11 news outlets

twitter: 2 X users

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 16 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 7,145 followers.

Development and Characterization of a Novel Non-Lytic Cancer Immunotherapy Using a Recombinant Arenavirus Vector Platform https://t.co/ep0fheZfuP

01 Nov 2021

Reply Repost Favourite

New research: Development and Characterization of a Novel Non-Lytic Cancer Immunotherapy Using a Recombinant Arenavirus Vector Platform: Engineered viral vectors represent a promising strategy to trigger antigen-specific antitumor T cell… https://t.co/uun3

14 Oct 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.